United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 592,899 | 358,880 | 281,497 | 210,943 | 159,632 |
| Cost of Goods | 67,674 | 40,861 | 30,066 | 22,261 | 17,028 |
| Gross Profit | 525,225 | 318,019 | 251,431 | 188,682 | 142,604 |
| Operating Expenses | 354,586 | 293,123 | 333,553 | 182,640 | 113,650 |
| Operating Income | 171,313 | 25,757 | -82,056 | 6,303 | 28,982 |
| Interest Expense | 19,710 | 12,875 | 11,439 | 14,281 | 482 |
| Other Income | 3,548 | 5,741 | 9,774 | 12,455 | 11,408 |
| Pre-tax Income | 155,151 | 18,623 | -83,721 | 4,477 | 39,908 |
| Income Tax | 43,945 | -695 | -34,394 | -7,876 | -34,057 |
| Net Income Continuous | 111,206 | 19,318 | -49,327 | 12,353 | 73,965 |
| Net Income Discontinuous | -5,290 | 144 | N/A | N/A | N/A |
| Net Income | $105,916 | $19,462 | $-49,327 | $12,353 | $73,965 |
| EPS Basic Total Ops | 1.89 | 0.37 | -1.08 | 0.29 | 1.61 |
| EPS Basic Continuous Ops | 1.98 | 0.36 | -1.08 | 0.29 | 1.61 |
| EPS Basic Discontinuous Ops | -0.09 | 0.01 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.78 | 0.35 | -1.08 | 0.28 | 1.53 |
| EPS Diluted Continuous Ops | 1.87 | 0.34 | -1.08 | 0.28 | 1.53 |
| EPS Diluted Discontinuous Ops | -0.09 | 0.01 | N/A | N/A | N/A |
| EBITDA(a) | $208,646 | $54,416 | $-63,849 | $19,366 | $30,446 |